Lenalidomide vs Placebo Maintenance After Stem Cell Transplant for Patients With Multiple Myeloma: Overall Survival and Progression-Free Survival After Adjusting for Treatment Crossover in CALGB
   Google Scholar   
Citation:
Haematologica vol 102 (S2) p 108, abstr p332
Meeting Instance:
EHA 2017
Year:
2017
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Myeloma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA180820  
Corr. Author:
 
Authors:
                 
Networks:
LAPS-MA036, LAPS-NY158, NE003   
Study
CALGB-100104
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: